The FDA Biologics Effectiveness and Safety (BEST) Initiative
The U.S. Food & Drug Administration (FDA) needs to make decisions on drug and vaccine safety and effectiveness with confidence. As a key collaborator, Optum Epidemiology generates reproducible results that inform decisions for COVID-19 vaccines. Learn more at bestinitiative.org.
Related healthcare insights
Article
See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.
E-book
Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.
Article
Discover insights from Dr. John Seeger’s recent participation at the Duke-Margolis Thirteenth Annual Sentinel Initiative Public Workshop.